Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

25.84
+0.08000.31%
Pre-market: 24.99-0.8500-3.29%05:08 EDT
Volume:2.47M
Turnover:64.77M
Market Cap:320.59M
PE:-2.72
High:27.99
Open:27.08
Low:25.03
Close:25.76
Loading ...

Nektar announces common stock offering, no amount given

TIPRANKS
·
13 hours ago

Nektar Therapeutics Shares Fall More Than 4% to $24.70 After the Bell Following Announcement of Proposed Public Stock Offering

THOMSON REUTERS
·
13 hours ago

Nektar Therapeutics Files Prospectus for Public Offering to Support Drug Development Initiatives

Reuters
·
13 hours ago

Nektar Therapeutics Announces Proposed Public Offering

THOMSON REUTERS
·
13 hours ago

Nektar Therapeutics Regains Nasdaq Compliance by June 2025

TIPRANKS
·
28 Jun

Nektar Therapeutics’ Phase 2b Study on Rezpegaldesleukin: A Potential Game-Changer for Atopic Dermatitis

TIPRANKS
·
27 Jun

Why Nektar Therapeutics Stock Was Red-Hot Today

Motley Fool
·
26 Jun

AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday

Benzinga
·
26 Jun

Nektar Shares Rise 40% to Hit More Than Two Year High After 182% Jump in Previous Two Sessions

THOMSON REUTERS
·
25 Jun

Piper Sandler Sticks to Its Buy Rating for Nektar Therapeutics (NKTR)

TIPRANKS
·
25 Jun

Rpt-Refile-Nektar Therapeutics : H.c. Wainwright Adjusts Target Price to $120 From $6.5 to Reflect 1-for-15 Reverse Stock Split (Clarifies PT Is Split Adjusted)

THOMSON REUTERS
·
25 Jun

U.S. RESEARCH ROUNDUP- Fedex, Omnicom Group, Texas Instruments

Reuters
·
25 Jun

Nektar Therapeutics : Jefferies Adjusts Target Price to $69 From $2 to Reflect 1-for-15 Reverse Stock Split

THOMSON REUTERS
·
25 Jun

BTIG Raises Nektar Therapeutics' Price Target to $100 From $60, Buy Rating Maintained

MT Newswires Live
·
25 Jun

Nektar price target raised to $100 from $60 at BTIG

TIPRANKS
·
25 Jun

William Blair Sticks to Their Hold Rating for Nektar Therapeutics (NKTR)

TIPRANKS
·
25 Jun

Nektar Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
25 Jun

Crude Oil Falls Sharply; US Current Account Deficit Widens In Q1

Benzinga
·
25 Jun

Wainwright sets over $100 target for Nektar on ‘paradigm-shifting’ data

TIPRANKS
·
25 Jun

Nektar Therapeutics : H.c. Wainwright Raises Target Price to $120 From $6.5

THOMSON REUTERS
·
25 Jun